Notable
Oral GnRH Antagonist (Linzagolix) Versus Injectable GnRH Antagonist in Controlled Ovarian Stimulation for In Vitro Fertilization: A Randomized Controlled Non-Inferiority Trial With a Concurrent Comparator Cohort Undergoing Progestin-Primed Ovarian Stimulation (PPOS)
Enrollment reduced: 195 → 120 participants
Also in this update: Phase changed: not specified → not applicable; Interventions modified
Centro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita)Not applicable NCT07732348 Registry history of NCT07732348 on ClinicalTrials.gov (opens the registry)
Updated